The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.

After spending years developing its endoscopic device treatment for patients with Type 2 diabetes, Fractyl Health is now ...

Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting ...

Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

While the company is prioritizing RJVA-001 and a lead program in obesity, it's pausing some R&D efforts and laying off 17 percent of its workforce.

SG Americas Securities LLC grew its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 796.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 54,921 shares of the ...

Haas has hired ex-Lotus and Alpine engineer Pierre Genon to manage its Formula 1 technical alliance with Toyota. Toyota ran ...

The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it ...